Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing

Molecular Oncology

Volumn 8, Issue 7, 2014, Pages 1208-1219

  Ma, Jie ^a   Mannoor, Kaiissar ^a   Gao, Lu ^a   Tan, Afang ^a   Guarnera, Maria A ^a   Zhan, Min ^a   Shetty, Amol ^a   Stass, Sanford A ^a   Xing, Lingxiao ^b   Jiang, Feng ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Deep sequencing; Lung cancer; MicroRNA; Therapy

Indexed keywords

MICRORNA; MICRORNA 135A 5P; MICRORNA 147B; MICRORNA 182 3P; MICRORNA 183 3P; MICRORNA 184; MICRORNA 196A 5P; MICRORNA 205 3P; MICRORNA 205 5P; MICRORNA 30A 3P; MICRORNA 486 5P; MICRORNA 577; MICRORNA 9 3P; MICRORNA 9 5P; MICRORNA 944; TRANSCRIPTOME; TUMOR MARKER; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NEXT GENERATION DEEP SEQUENCING; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; LUNG; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS; TRANSCRIPTOME;

EID: 84908501196     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.03.019     Document Type: Article

References (46)

1. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113:673-676.
2. Azzoli C.G., Patel J.D., Krug L.M., Miller V., James L., Kris M.G., Ginsberg M., Subzwari S., Tyson L., Dunne M., et al. Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial. J.Thorac. Oncol. 2011, 6:1915-1922.
3. Bishop J.A., Benjamin H., Cholakh H., Chajut A., Clark D.P., Westra W.H. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin. Cancer Res. 2010, 16:610-619.
4. Brambilla E., Travis W.D., Colby T.V., Corrin B., Shimosato Y. The new World Health Organization classification of lung tumours. Eur. Respir. J. 2001, 18:1059-1068.
5. Chugh P., Dittmer D.P. Potential pitfalls in microRNA profiling. Wiley Interdiscip. Rev. RNA 2012, 3:601-616.
6. Del Vescovo V., Cantaloni C., Cucino A., Girlando S., Silvestri M., Bragantini E., Fasanella S., Cuorvo L.V., Palma P.D., Rossi G., et al. miR-205 expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am. J. Surg. Pathol. 2011, 35:268-275.
7. Friedlander M.R., Chen W., Adamidi C., Maaskola J., Einspanier R., Knespel S., Rajewsky N. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 2008, 26:407-415.
8. Grondin S.C., Liptay M.J. Current concepts in the staging of non-small cell lung cancer. Surg. Oncol. 2002, 11:181-190.
9. Hamfjord J., Stangeland A.M., Hughes T., Skrede M.L., Tveit K.M., Ikdahl T., Kure E.H. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 2012, 7:e34150.
10. Hirsch F.R., Spreafico A., Novello S., Wood M.D., Simms L., Papotti M. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J.Thorac. Oncol. 2008, 3:1468-1481.
11. Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., Chen Y., Xu L., Zen K., Zhang C., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J.Clin. Oncol. 2010, 28:1721-1726.
12. Jima D.D., Zhang J., Jacobs C., Richards K.L., Dunphy C.H., Choi W.W., Au W.Y., Srivastava G., Czader M.B., Rizzieri D.A., et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010, 116:e118-127.
13. Kario E., Marmor M.D., Adamsky K., Citri A., Amit I., Amariglio N., Rechavi G., Yarden Y. Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J.Biol. Chem. 2005, 280:7038-7048.
14. Keller A., Backes C., Leidinger P., Kefer N., Boisguerin V., Barbacioru C., Vogel B., Matzas M., Huwer H., Katus H.A., et al. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Mol. Biosyst. 2011, 7:3187-3199.
15. Kobayashi D., Nomoto S., Kodera Y., Fujiwara M., Koike M., Nakayama G., Ohashi N., Nakao A. Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis. World J. Surg. 2012, 36:362-372.
16. Kozubek J., Ma Z., Fleming E., Duggan T., Wu R., Shin D.G., Dadras S.S. In-depth characterization of microRNA transcriptome in melanoma. PLoS One 2013, 8:e72699.
17. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39(Database issue). D152-7.
18. Landi M.T., Zhao Y., Rotunno M., Koshiol J., Liu H., Bergen A.W., Rubagotti M., Goldstein A.M., Linnoila I., Marincola F.M., et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res. 2010, 16:430-441.
19. Lang M.F., Yang S., Zhao C., Sun G., Murai K., Wu X., Wang J., Gao H., Brown C.E., Liu X., et al. Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS One 2012, 7:e36248.
20. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
21. Lebanony D., Benjamin H., Gilad S., Ezagouri M., Dov A., Ashkenazi K., Gefen N., Izraeli S., Rechavi G., Pass H., et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J.Clin. Oncol. 2009, 27:2030-2037.
22. Li N., Ma J., Guarnera M.A., Fang H., Cai L., Jiang F. Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer. J.Cancer Res. Clin. Oncol. 2014, 140:145-150.
23. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
24. Ma J., Li N., Guarnera M., Jiang F. Quantification of plasma miRNAs by digital PCR for Cancer diagnosis. Biomark Insights 2013, 8:127-136.
25. Mukhopadhyay S., Katzenstein A.L. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am. J. Surg. Pathol. 2011, 35:15-25.
26. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J.Thorac. Cardiovasc. Surg. 1988, 96:440-447.
27. Osanto S., Qin Y., Buermans H.P., Berkers J., Lerut E., Goeman J.J., van Poppel H. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 2012, 7:e38298.
28. Perdomo C., Campbell J.D., Gerrein J., Tellez C.S., Garrison C.B., Walser T.C., Drizik E., Si H., Gower A.C., Vick J., et al. MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:18946-18951.
29. Pradervand S., Weber J., Lemoine F., Consales F., Paillusson A., Dupasquier M., Thomas J., Richter H., Kaessmann H., Beaudoing E., et al. Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. Biotechniques 2010, 48:219-222.
30. Quinlan A.R., Hall I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842.
31. Raponi M., Dossey L., Jatkoe T., Wu X., Chen G., Fan H., Beer D.G. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009, 69:5776-5783.
32. Rohr C., Kerick M., Fischer A., Kuhn A., Kashofer K., Timmermann B., Daskalaki A., Meinel T., Drichel D., Borno S.T., et al. High-throughput miRNA and mRNA sequencing of paired colorectal normal, tumor and metastasis tissues and bioinformatic modeling of miRNA-1 therapeutic applications. PLoS One 2013, 8:e67461.
33. Schee K., Lorenz S., Worren M.M., Gunther C.C., Holden M., Hovig E., Fodstad O., Meza-Zepeda L.A., Flatmark K. Deep sequencing the MicroRNA transcriptome in colorectal Cancer. PLoS One 2013, 8:e66165.
34. Shen J., Jiang F. Applications of MicroRNAs in the diagnosis and prognosis of lung Cancer. Expert Opin. Med. Diagn. 2012, 6:197-207.
35. Shen J., Liao J., Guarnera M.A., Fang H., Cai L., Stass S.A., Jiang F. Analysis of MicroRNAs in sputum to improve computed tomography for lung Cancer diagnosis. J.Thorac. Oncol. 2014, 9:33-40.
36. Shen J., Liu Z., Todd N.W., Zhang H., Liao J., Yu L., Guarnera M.A., Li R., Cai L., Zhan M., et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011, 11:374.
37. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
38. Tili E., Michaille J.J., Gandhi V., Plunkett W., Sampath D., Calin G.A. miRNAs and their potential for use against cancer and other diseases. Future Oncol. 2007, 3:521-537.
39. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., Beer D.G., Powell C.A., Riely G.J., Van Schil P.E., et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J.Thorac. Oncol. 2011, 6:244-285.
40. Wang J., Tian X., Han R., Zhang X., Wang X., Shen H., Xue L., Liu Y., Yan X., Shen J., et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 2014, 33(9):1181-1189.
41. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., Cormier Y., Goss G., Inculet R., Vallieres E., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N.Engl. J. Med. 2005, 352:2589-2597.
42. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., Dowsett M., Fitzgibbons P.L., Hanna W.M., Langer A., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J.Clin. Oncol. 2007, 25:118-145.
43. Xie Y., Todd N.W., Liu Z., Zhan M., Fang H., Peng H., Alattar M., Deepak J., Stass S.A., Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010, 67:170-176.
44. Xing L., Todd N.W., Yu L., Fang H., Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod. Pathol. 2010, 23:1157-1164.
45. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
46. Yu L., Todd N.W., Xing L., Xie Y., Zhang H., Liu Z., Fang H., Zhang J., Katz R.L., Jiang F. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int. J. Cancer 2010, 127:2870-2878.